石杉碱甲的作用
石杉碱甲(Huperzine A,Hup A)是从我国中草药蛇足石杉(Huperziaserrata)中提取出的新型石杉类生物碱有效单体,是一种具有高效、高选择性且可逆性的中枢性乙酰胆碱酯酶(Acetylcholinesterase,AChE)抑制剂,临床上常用于治疗各种疾病,例如瘀伤、感染、风湿病、精神分裂症、重症肌无力和发热等。Hup A 可以逆转或减弱多种不同动物模型(包括啮齿类动物和非人灵长类动物等)的认知损害,并且可以改善人类的学习和记忆缺陷。事实上,Hup A的神经保护作用,不仅仅是由于其对AChE抑制作用,并且它具有多个分子作用的靶点。
(一)调控APP代谢途径
APP在体内的代谢途径主要分为两种,即由α-分泌酶介导的非Aβ途径和由β-分泌酶和γ-分泌酶共同介导的Aβ途径。研究显示,Hup A调节APP的代谢途径与蛋白激酶C(Protein kinase C,PKC)的活化有关,通过激活毒蕈碱乙酰胆碱(Moscarinic acetylcholine,mACh)受体M1 和M3 亚型,细胞内PLC-PKC 信号传导途径被激活,从而使经PKC 磷酸化的酪氨酸发挥作用,促使α-分泌酶活化,进而使分泌型淀粉样蛋白前体蛋白α的分泌增加,Aβ的水平降低[52]。Zhang等[53]的研究发现,通过脑室内注射Aβ1-40 建立的AD 大鼠模型通过腹腔注射Hup A 可以明显提高大鼠体内由Aβ导致的分泌型APPα分泌减少;而在经Aβ1-40 处理过的HEK293sw 细胞中,给予Hup A 后,APP 的水平显著增加。Yan 等[54]发现Hup A 可以激活M1 mAChR/PKC 级联和MAPK 信号传导,从而增强APP 的非Aβ途径。这些研究结果表明Hup A可能通过上调PKC,来影响APP的代谢,从而改善AD的学习记忆能力和认知功能。
(二)抗氧化应激
研究发现,Hup A可以提高AD模型豚鼠的额叶、顶叶、颞叶和小脑中三价铁还原抗氧化力、谷胱甘肽还原酶活性和氧化应激标记物(如转氨酶、血尿素氮和葡萄糖等)水平[55]。Hup A可以明显改善D-半乳糖诱导的老化小鼠的学习记忆障碍,降低脑组织中一氧化氮含量,抑制NOS活性,提高谷胱甘肽过氧化物酶和琥珀酸脱氢酶活性,降低胞浆钙离子水平。研究表明,在分离的大鼠脑线粒体中,Hup A除了改善Aβ诱导的线粒体呼吸功能下降、ATP 合成减少、线粒体呼吸链酶失活和跨膜电位的降低,还能有效防止Aβ诱导的线粒体肿胀、ROS过度生成和细胞色素c释放。Gao等[56]研究发现用Hup A 孵育PC12 模型细胞2h,不仅减弱了细胞中由Aβ引起的细胞氧化应激损伤,而且可使未受伤害的正常细胞中的ATP浓度升高和ROS 生成减少。上述结果表明Hup A 能提高细胞的抗氧化能力,在治疗AD中起一定的神经保护作用。
(三)对中枢神经递质的调控作用
1.胆碱能神经传递系统
Hup A是一种高选择性的可逆性胆碱酯酶抑制剂,易通过血脑屏障,其抑制方式是典型的混合型抑制,兼顾竞争性和非竞争性,抑制作用明显优于加兰他敏、多奈哌齐和他克林。Hup A 通过与AChE 可逆性结合,减少ACh的水解,使神经突触间隙的ACh含量明显升高,并通过激活突触后膜上的N受体,兴奋胆碱能神经元,从而增强学习记忆相关脑区神经元的兴奋性,进而发挥增强学习记忆能力,改善认知行为功能。有研究表明,Hup A 对丁酰胆碱酯酶(Butyrylcholinesterase,BuChE)抑制作用较弱,因此外周ACh 水平升高作用不明显,从而减少了恶心、呕吐等外周胆碱能不良反应[57]。
2.单胺类神经传递系统
中枢神经系统是一个复杂的网络,其中某一神经传递系统通常会干扰其他神经传递系统。研究表明,ACh系统与去甲肾上腺素(NE)系统、多巴胺(DA)系统之间存在相互作用,共同影响学习和记忆能力。这些神经传递系统的失调可能会导致包括AD 在内的各种神经系统退行性疾病。Liang 等[58]应用清醒大鼠双探针脑微透析及高效液相色谱电化学检测技术研究表明,口服Hup A 能够显著提高大鼠中前额叶皮层及腹侧海马内ACh水平和中前额叶皮层突触间隙DA及NA水平,但对5-羟色胺水平没有影响,对DA的作用强于NA,但对二者的作用峰值及作用持续时间均弱于对ACh的作用。总而言之,细胞外ACh含量的升高可能同时会引起NA和DA含量的升高,因此Hup A可以通过提高患者脑组织内的ACh及NA、DA等神经递质的水平,发挥对受损神经的保护作用。
3.谷氨酸介导的兴奋性神经传递系统
谷氨酸是大脑中最丰富的神经递质,与长时程增强记忆的形成密切相关。NMDA 受体是Glu 受体的一个亚型。AD 患者脑内谷氨酸水平过高,提示存在NMDA 受体的慢性激活。Hup A 作用于谷氨酸介导的兴奋性神经传递系统。有研究表明,将神经元细胞用Hup A预处理45min后使其暴露于NMDA中,可以抑制NMDA诱导的毒性作用。另外,Hup A可以选择性抑制NMDA 诱导电流,且与NMDA 受体的变构调节位点的调节剂具有竞争作用。这些结果表明Hup A 具有拮抗NMDA 受体的作用,可以减弱由谷氨酸介导的兴奋性细胞毒性。
(四)调节神经生长因子信号
神经生长因子(Nerve growth factor,NGF)是重要的神经细胞生长调节因子。年龄相关的基底前脑胆碱能神经元变性通常发生于AD早期,并且与AD的认知功能下降相关。大量的实验已经表明,减少基底前脑胆碱能神经元细胞体上的NGF水平,会导致神经元标记物的丢失和减少,形成酷似AD患者的典型病变。在AD的终末阶段,出现基底核区含ACh的皮质投影神经元的选择性变性,可能与NGF 及其低亲和力受体P75 和高亲和力受体TrkA 三者之间的功能紊乱有关。NGF 增强了APP 的非Aβ途径,并减少APP/PS1 转基因小鼠脑中的Aβ生成。然而,NGF 不能穿过血脑屏障。因此,通过药物刺激内源性NGF 的产生,或通过研究能够穿过血脑屏障的化合物来模拟NGF 的活性是保护中枢神经系统的新途径。Tang 等[59]研究发现,Hup A 可以显著增加带有轴突的PC12 细胞的数量,但对细胞活力无明显影响。Hup A还可以明显上调NGF mRNA的水平和低亲和力NGF 受体p75的表达。同年,Tang 等[60]通过H2O2介导的神经毒性细胞模型实验进行进一步的探索,实验结果表明Hup A通过TrkA介导的MAPK/ERK途径来实现对NGF信号传导的调节作用,该调节作用可以被K252α(与TrkA 受体信号传导活化相关的磷酸化抑制剂)和PD98059(MAPK/ERK 抑制剂)所阻断。结果表明,Hup A 对神经细胞的保护作用由上调的NGF和NGF受体来介导。
(五)抑制神经细胞凋亡
有研究表明,Aβ的异常沉积、炎症反应和氧化应激损伤均能够促进神经细胞的凋亡,其中Aβ的直接神经毒性作用是最常见的原因。Aβ的神经毒性可造成细胞活性下降、线粒体功能紊乱、引起细胞凋亡。在中枢神经系统中,NF-κB的活化与神经细胞凋亡的易感性增加相关。Hup A可通过阻止NF-κB核易位,抑制D-半乳糖诱导的神经血管损伤和血脑屏障功能障碍,从而抑制神经细胞凋亡。另外,Hup A通过抑制Aβ1-42诱导的小胶质细胞炎症反应,使神经干细胞在神经干细胞和小胶质细胞共培养系统中免受Aβ诱导的细胞凋亡。
综上所述,我国中药资源丰富,从天然植物中筛选和开发出疗效更高、毒性更小的中药及其单体来防治AD具有独特的优势。以现代医学对AD的病理假说为基础,从分子生物学的角度出发,利用中药多途径、多靶点、多层次的特点,进一步探讨中药在治疗AD方面的作用机制,有助于提高中药治疗AD的临床价值。
参考文献
[1]李龙宣,茹立强,殷光甫,等.丹参酮治疗阿尔茨海默病样大鼠的作用机制[J].中华老年心脑血管病杂志,2003,5(5):342-345.
[2]李林,夏保芦,茹立强.丹参酮对两种学习记忆功能障碍模型大鼠治疗作用的实验研究[J].华中科技大学学报:医学版,2008,37(6):819-822.
[3]谢明,成志.丹参酮对阿尔茨海默病样大鼠海马内诱导型一氧化氮合酶mRNA 和乙酰胆碱酯酶表达的影响[J].中国现代医学杂志,2008,18(8):1005-1007.
[4]Wolk DA,Klunk W.Update on amyloid imaging:from healthy aging to Alzheimer’s disease[J].Curr Neurol Neurosci Rep,2009,9:345-352.
[5]Yao BC,Deng ZH,Sun TM,et al.Effect of Aβ(1-40)on expression of synaptophysin and synaptic number of hippocampal neurous in rat after injection of βamyloid protein 1-40 into hippocampus[J].Chin J Mod Med,2007,17(2):153-156.
[6]Liu YH,Wang YR,Xiang Y,et al.Clearance of amyloid - beta in alzheimer’s disease:shifting the action site from center to periphery[J].Mol Neurobiol,2015,51(1):1-7.
[7]Liu T,Jin H,Sun Q,et al.The neuroprotective effects of tanshinone ⅡA on β-amyloid-induced toxicity in rat cortical neurons[J].Neuropharmacology,2010,7(59):595-604.
[8]Li J,Wen PY,Li WW,et al.Upregulation effects of Tanshinone ⅡA on the expressions of NeuN,Nissl body,and IκB and downregulation effects on the expressions of GFAP and NF-κB in the brain tissues of rat models of Alzheimer’s disease[J].Neuroreport,2015,26(13):758-766.
[9]Qian YH,Xiao Q,Xu J.The protective effects of tanshinone ⅡA on betaamyloid protein(1-42)-induced cytotoxicity via activation of the Bcl-xL pathway in neuron[J].Brain Res Bull,2012,88(4):354-358.
[10]Dong H,Mao S,Wei J,et al.Tanshinone ⅡA protects PC12 cells from βamyloid(25-35)-induced apoptosis via PI3K/Akt signaling pathway[J].Mol BiolRep,2012,39(6):6495-6503.
[11]Wang A,Das P,Rd SR,et al.Robust amyloid clearance in a mouse model of AD provides novel insights into the mechanism of Aβ immunotherapy[J].J Neurosci,2011,31(11):4124-4136.
[12]Blennow K,Zetterberg H,Rinne JO,et al.Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease[J].Arch Neurol,2012,69(8):1002-1010.
[13]Zhang WJ,Feng J,Zhou R,et al.Tanshinone ⅡA protects the human blood-brain barrier model from leukocyte-associated hypoxia-reoxygenation injury[J].Eur J Pharmacol,2010,648(1-3):146-152.
[14]Jiang P,Li C,Xiang Z,et al.Tanshinone ⅡA reduces the risk of Alzheimer’s disease by inhibiting iNOS,MM-2 and NF-κBp65 transcription and translation in the temporal lobes of rat models of Alzheimer’s disease[J].Mol Med Rep,2014,10(2):689-694.
[15]Zawia NH,Lahiri DK,Cardozo-Pelaez F.Epigenetics,oxidative stress,and Alzheimer disease[J].Free Radic Biol Med,2009,46(9):1241-1249.
[16]Tang Q,Han R,Xiao H,et al.Neuroprotective effects of tanshinone ⅡA and/or tetramethylpyrazine in cerebral ischemic injury in vivo and in vitro[J].Brain Res,2012,1488:81-91.
[17]蒋平,陈鸣,吕军,等.丹参酮ⅡA对阿尔茨海默病模型大鼠海马MMP-2、iNOS表达及自由基释放的影响[J].第二军医大学学报,2010,31(4):380-384.
[18]Zhang F,Zheng W,Pi R,et al.Cryptotanshinone protects primary rat cortical neurons from glutamate - induced neurotoxicity via the activation of the phosphatidylinositol 3-kinase/Akt signaling pathway[J].Exp Brain Res,2009,193(1):109-118.
[19]Kim DH,Jeon SJ,Jung JW,et al.Tanshinone congeners improve memory impairments induced by scopolamine on passive avoidance tasks in mice[J].Eur J Pharmacol,2007,574(2/3):140-147.
[20]Melo JB,Sousa C,Garcao P,et al.Galantamine protects against oxidativestress induced by amyloid-beta peptide in cortical neurons[J].Eur J Neurosci,2009,29(3):455-464.
[21]Chen Y,Wu X,Yu S,et al.Neuroprotective capabilities of tanshinone Ⅱa against cerebral ischemia/reperfusion injury via anti-apoptotic pathway in rats[J].Biol Pharm Bull,2012,35(2):164-170.
[22]温蒲圆,罗浩,周丽,等.丹参酮ⅡA对阿尔茨海默病模型大鼠脑组织caspase-3、Akt 与NF-κB 表达的影响[J].细胞与分子免疫学杂志,2014,30(2):155-159.(https://www.daowen.com)
[23]李建,王芳,周军,等.丹参酮ⅡA 对AD 大鼠脑组织p53,pp53表达及细胞凋亡的影响[J].中南大学学报:医学版,2015,40(11):1210-1216.
[24]何治,潘志红,鲁文红.丹参酮ⅡA 对血管性痴呆大鼠的神经保护作用机制[J].中国中药杂志,2010,35(14):1883-1886.
[25]Shen JL,Chen YS,Lin JY,et al.Neuron regeneration and proliferation effects of Danshen and tanshinone ⅡA[J].Evid Based Complement Alternat Med,2011,2011:378907.
[26]Liu X,Guo CY,Ma XJ,et al.Anti-inflammatory effects of tanshinone ⅡA on atherosclerostic vessels of ovariectomized ApoE mice are mediated by estrogen receptor activation and through the ERK signaling pathway[J].Cell Physiol Biochem,2015,35(5):1744-55.
[27]Kim MS,Yu JM,Kim HJ,et al.Ginsenoside Re and Rd enhance the expression of cholinergic markers and neuronal differentiation in Neuro-2a cells[J].Biol Pharm Bull,2014,37(5):826-833.
[28]Kim S,Kim T,Ahn K,et al.Ginsenoside Rg3 antagonizes NMDA receptors through a glycine modulatory site in rat cultured hippocampal neurons[J].Biochem Biophys Res Commun,2004,323(2):416-424.
[29]MacLeod R,Hillert EK,Cameron RT,et al.The role and therapeutic targeting of α,β and γ-secretase in Alzheimer’s disease[J].Future Sci OA,2015,1(3):1-16.
[30]Chen LM,Lin N,Zhang J,et al.Mechanism of ginsenoside Rg1regulating the activity of β secretase in N2a/APP695 cells[J].Natl Med J China,2012,92(5):330-335.
[31]Yan X,Hu G,Yan W,et al.Ginsenoside Rd promotes non -amyloidogenic pathway of amyloid precursor protein processing by regulating phosphorylation of estrogen receptor alpha[J].Life Sci,2017,168:16-23.
[32]Zhao HH,Di J,Liu WS,et al.Involvement of GSK3 and PP2A in ginsenoside Rb1’s attenuation of aluminum-induced tau hyperphosphorylation[J].Behav Brain Res,2013,241:228-234.
[33]李玺,张欣,袁海峰,等.人参皂苷Rg1 对AD 模型大鼠脑片P-Tau,caspase-3表达的影响[J].中国中药杂志,2010,35(3):369-372.
[34]Heneka MT,Golenbock DT,Latz E.Innate immunity in Alzheimer’s disease[J].Nat Immunol,2015,16(3):229-236.
[35]Yu S,Zhou X,Li F,et al.Microbial transformation of ginsenoside Rb1,Re and Rg1 and its contribution to the improved anti-inflammatory activity of ginseng[J].Sci Rep,2017,7(1):138.
[36]Liu J,Yan X,Li L,et al.Ginsenoside Rd improves learning and memory ability in app transgenic mice[J].J Mol Neurosci,2015,57(4):522-528.
[37]Chu S,Gu J,Feng L,et al.Ginsenoside Rg5 improves cognitive dysfunction and beta-amyloid deposition in STZ-induced memory impaired rats via attenuating neuroinflammatory responses[J].Int Immunopharmacol,2014,19(2):317-326.
[38]Li J,Cai D,Yao X,et al.Protective effect of ginsenoside Rg1 on hematopoietic stem/progenitor cells through attenuating oxidative stress and the Wnt/β-catenin signaling pathway in a mouse model of d-Galactose-induced Aging[J].Int J Mol Sci,2016,17(6):849.
[39]贾立云,潘晓华,刘晶,等.人参皂苷Rb1、Re对Aβ25-35诱导SK-N-SH细胞损伤的保护作用[J].山东大学学报医学版,2011,49(4):33-37.
[40]Gong L,Li SL,Li H,et al.Ginsenoside Rg1 protects primary cultured rat hippocampal neurons from cell apoptosis induced by β-amyloid protein[J].PharmBiol,2011,49(5):501-507.
[41]Liu JF,Yan XD,Qi LS,et al.Ginsenoside Rd attenuates Aβ25-35-induced oxidative stress and apoptosis in primary cultured hippocampal neurons[J].Chem Biol Interact,2015,239:12-18.
[42]Blanc F,Poisbeau P,Sellal F,et al.Alzheimer disease,memory and estrogen[J].Rev Neurol(Paris),2010,166(4):377-388.
[43]Shi C,Zheng DD,Fang L,et al.Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt[J].Biochim Biophys Acta,2012,1820(4):453-460.
[44]Hao K,Gong P,Sun SQ,et al.Beneficial estrogen-like effects of ginsenoside Rb1,an active component of Panax ginseng,on neural 5-HT disposition and behavioral tasks in ovariectomized mice[J].Eur J Pharmacol,2011,659(1):15-25.
[45]Huang DS,Lin HY,Lee-Chen GJ,et al.Treatment with a Ginkgo biloba extract,EGb 761,inhibits excitotoxicity in an animal model of spinocerebellar ataxia type 17[J].Drug Des Devel Ther,2016,10:723-731.
[46]王暖,黄红莉,周昊,等.银杏叶提取物对阿尔茨海默病大鼠的神经保护作用及其机制探讨[J].山东医药,2013,53(36):31-33.
[47]Liu L,Zhang C,Kalionis B,et al.EGb761 protects against Aβ1-42 oligomer-induced cell damage via endoplasmic reticulum stress activation and Hsp70 protein expression increase in SH-SY5Y cells[J].Exp Gerontol,2016,75:56-63.
[48]李进东.银杏叶提取物对老年痴呆症大鼠学习空间学习记忆能力的影响[J].湖北中医杂志,2013,35(9):26-27.
[49]von Gunten A,Schlaefke S,uberla K.Efficacy of Ginkgo biloba extract EGb 761 in dementia with behavioural and psychological symptoms:A systematic review[J].World J Biol Psychiatry,2016,17(8):622-633.
[50]Heinen-Kammerer T,Motzkat K,Daniel D,et al.The situation of patients with dementia may be rectified by Ginkgo biloba.Results of a health services research study concerning the ability of patients with dementia,quality of life of thenursing family member sand total treatment costs[J].MMW Fortschr Med,2005,147(Suppl 3):127-133.
[51]Zamberlam CR,Vendrasco NC,Oliveira DR,et al.Effects of standardized Ginkgo biloba extract on the acquisition,retrieval and extinction of conditioned suppression:Evidence that short-term memory and long-term memory are differentially modulated[J].Physiol Behav,2016,165:55-68.
[52]Peng Y,Lee DY,Jiang L,et al.Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695[J].Neuroscience,2007,150(2):386-395.
[53]Zhang HY,Yan H,Tang XC.Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-alpha in intracerebroventricular betaamyloid-(1-40)infused rats and human embryonic kidney 293 Swedish mutant cells[J].Neurosci Lett,2004,360(1/2):21-24.
[54]Yan H,Zhang HY,Tang XC.Involvement of M1 - muscarinic acetylcholine receptors,protein kinase C and mitogen-activated protein kinase in the effect of huperzine A on secretory amyloid precursor protein-alpha[J].Neuroreport,2007,18(7):689-692.
[55]Pohanka M,Zemek F,Bandouchova H,et al.Toxicological scoring of Alzheimer ' s disease drug huperzine in a guinea pig model[J].Toxicol Mech Methods,2012,22(3):231-235.
[56]Gao X,Tang XC.Huperzine A attenuates mitochondrial dysfunction in beta-amyloid-treated PC12 cells by reducing oxygen free radicals accumulation and improving mitochondrial energy metabolism[J].J Neurosci Res,2006,83(6):1048-1057.
[57]Zangara A.The psychopharmacology of huperzine A:an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease[J].Pharmacol Biochem Behav,2003,75(3):675-686.
[58]Liang YQ,Tang XC.Comparative studies of huperzine A,donepezil,andrivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5 -hydroxytryptamine levels in freely-moving rats[J].Acta Pharmacol Sin,2006,27(9):1127-1136.
[59]Tang LL,Wang R,Tang XC.Effects of huperzine A on secretion of nerve growth factor in cultured rat cortical astrocytes and neurite outgrowth in rat PC12 cells[J].Acta Pharmacol Sin,2005,26(6):673-678.
[60]Tang LL, Wang R, Tang XC.Huperzine A protects SHSY5Y neuroblastoma cells against oxidative stress damage via nerve growth factor production[J].Eur J Pharmacol,2005,519(1/2):9-15.
(李乃静 柳云恩 王佳贺 杜 岩)